Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial

Ítems similars

• Low rates of nucleoside reverse transcriptase inhibitor (NRTI) resistance detected in a well monitored cohort in South Africa accessing antiretroviral therapy
  per: Wallis, Carole L, et al.
  Publicat: (2011)
• Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy?
  per: Orrell, Catherine, et al.
  Publicat: (2011)
• Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living with HIV and HBV
  per: Bhattacharya, Debika, et al.
  Publicat: (2021)
• Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa
  per: Wallis, Carole L., et al.
  Publicat: (2011)
• Moderate Levels of Pre-Treatment HIV-1 Antiretroviral Drug Resistance Detected in the First South African National Survey
  per: Steegen, Kim, et al.
  Publicat: (2016)